Loading...
XASXBMT
Market cap46mUSD
Jan 08, Last price  
0.27AUD
1D
0.00%
1Q
-8.47%
IPO
-12.20%
Name

Carnaby Resources Ltd

Chart & Performance

D1W1MN
XASX:BMT chart
P/E
P/S
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
21.22%
Rev. gr., 5y
-6.94%
Revenues
0k
000004,380,713000
Net income
-12m
L-1.21%
-117,582-602,52000-3,123,086371,382-8,216,492-12,233,779-12,086,344
CFO
-12m
L+6.85%
-3,872-201,30200-2,532,694677,681-8,161,925-11,272,590-12,045,297
Earnings
Feb 12, 2025

Profile

Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data. It also provides RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; and Codexpert, a searchable eBook application that offers classification reference information for clinical coding patient records. The company offers advisory and auditing solution, such as desktop analysis, data maturity index, and physical audits. It serves customers through channel partners. The company was formerly known as PKS Holdings Limited and changed its name to Beamtree Holdings Limited in August 2021. Beamtree Holdings Limited was founded in 1996 and is headquartered in Redfern, Australia.
IPO date
Aug 30, 2016
Employees
95
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
101
12,780
9,771
Unusual Expense (Income)
NOPBT
(101)
(12,780)
(9,771)
NOPBT Margin
Operating Taxes
822
3
(2)
Tax Rate
NOPAT
(923)
(12,780)
(9,771)
Net income
(12,086)
-1.21%
(12,234)
48.89%
(8,216)
-2,312.41%
Dividends
Dividend yield
Proceeds from repurchase of equity
(7)
18,649
18,743
BB yield
0.01%
-12.03%
-16.12%
Debt
Debt current
47
19
46
Long-term debt
84
19
37
Deferred revenue
Other long-term liabilities
496
375
357
Net debt
(10,658)
(27,265)
(18,227)
Cash flow
Cash from operating activities
(12,045)
(11,273)
(8,162)
CAPEX
(4,411)
(190)
(1,137)
Cash from investing activities
(3,506)
586
(370)
Cash from financing activities
(173)
19,680
19,802
FCF
(958)
(12,780)
(9,944)
Balance
Cash
10,312
26,941
17,947
Long term investments
478
362
362
Excess cash
10,789
27,303
18,309
Stockholders' equity
26,777
31,608
23,526
Invested Capital
16,549
4,699
5,638
ROIC
ROCE
EV
Common stock shares outstanding
163,974
147,609
129,176
Price
0.48
-54.29%
1.05
16.67%
0.90
160.87%
Market cap
78,707
-49.22%
154,990
33.31%
116,259
179.73%
EV
68,049
127,724
98,032
EBITDA
(101)
(12,686)
(9,720)
EV/EBITDA
Interest
7
9
8
Interest/NOPBT